US Broker Ratings

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Impressive Revenue Growth and 30.63% Potential Upside for Investors

BridgeBio Pharma, Inc. (NASDAQ: BBIO) is carving a niche in the biotechnology sector with a focus on developing therapeutics for genetic diseases and cancers. Based in the United States, this..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: Exploring a 44% Upside Potential

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is catching the attention of investors with an enticing potential upside of 44.41%. As a prominent player in the biotechnology industry, Madrigal is focused on..

Axsome Therapeutics, Inc. (AXSM) Investor Outlook: Exploring a Potential 18.89% Upside in CNS Innovations

Axsome Therapeutics, Inc. (NASDAQ: AXSM) has become a prominent player in the biotechnology sector, focusing on novel therapies for central nervous system (CNS) disorders. With a market capitalization of $9.14..

ADMA Biologics Inc (ADMA) Stock Analysis: Unlocking a 59.52% Upside in the Biotech Arena

ADMA Biologics Inc (NASDAQ: ADMA) stands as a compelling opportunity in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $3.84 billion, this biopharmaceutical company is..

AstraZeneca PLC (AZN) Stock Analysis: Navigating a -24.17% Potential Downside Amid Strong Revenue Growth

AstraZeneca PLC (NASDAQ: AZN), a stalwart in the healthcare sector, has captured the attention of investors worldwide. With a market capitalization of $318.66 billion, this UK-based biopharmaceutical giant operates at..

Nuvalent, Inc. (NUVL) Stock Analysis: A 41.49% Potential Upside in the Biotechnology Sector

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to treating cancer. With a market capitalization of $7.83 billion, Nuvalent..

Ascendis Pharma A/S (ASND) Stock Analysis: A 31.7% Potential Upside in Biotech Innovation

Ascendis Pharma A/S (NASDAQ: ASND) is making waves in the biotechnology sector with its innovative TransCon-based therapies, capturing the attention of investors seeking growth in the healthcare industry. As a..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Exploring a Stable Player with a 2.11% Dividend Yield and Modest Growth Prospects

Smith & Nephew SNATS, Inc. (NYSE: SNN) is a prominent entity in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $15.36 billion, this UK-based..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A 55.89% Potential Upside in the Biotech Space

TG Therapeutics, Inc. (NASDAQ: TGTX) stands as a compelling player in the biotechnology sector, particularly for investors keen on the healthcare industry. With a market capitalization of $4.52 billion, TG..

Vaxcyte, Inc. (PCVX) Stock Analysis: A Biotech Gem with 88.75% Potential Upside

Vaxcyte, Inc. (NASDAQ: PCVX) is catching the attention of investors with its potential for significant upside, estimated at an impressive 88.75%. As a clinical-stage company making strides in vaccine innovation,..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Navigating a 2.34% Potential Upside Amidst Healthcare Ambitions

Dr. Reddy’s Laboratories Ltd (NYSE: RDY) stands as a formidable player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $11.87..

Fresenius Medical Care AG (FMS) Stock Analysis: Unveiling a 15% Upside Potential in the Healthcare Sector

Fresenius Medical Care AG (NYSE: FMS), a leader in the healthcare sector specializing in dialysis and related services, presents an intriguing opportunity for investors with a potential upside of 15.44%...

Solventum Corporation (SOLV) Stock Analysis: A Promising 18.13% Upside in the Healthcare Sector

Solventum Corporation (NASDAQ: SOLV), a dynamic player in the healthcare sector, has been capturing investor attention with its robust product offerings and strategic market position. Headquartered in Maplewood, Minnesota, the..

Henry Schein, Inc. (HSIC) Stock Analysis: Navigating Growth in Healthcare Distribution with a 5.20% Revenue Surge

Henry Schein, Inc. (NASDAQ: HSIC) stands as a pivotal player in the healthcare distribution sector, a cornerstone in the medical distribution industry with a substantial market capitalization of $9.48 billion...

Alkermes plc (ALKS) Stock Analysis: Strong Buy Ratings and a Promising 32% Upside Potential

Alkermes plc (NASDAQ: ALKS), a notable player in the biopharmaceutical industry, is attracting significant attention from investors due to its promising growth potential and strong market positioning. With a market..

Masimo Corporation (MASI) Stock Analysis: 41% Potential Upside Sparks Investor Optimism

Masimo Corporation (MASI), a prominent player in the healthcare sector specializing in medical devices, presents a compelling case for investors looking for growth potential. With a market capitalization of $6.99..

AptarGroup, Inc. (ATR) Stock Analysis: Exploring a 13.22% Potential Upside in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR) stands as a formidable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $9.36 billion, this American..

Merck & Company, Inc. (MRK) Investor Outlook: Strong Buy Ratings and Promising Growth in Healthcare

Merck & Company, Inc. (NYSE: MRK), a titan in the healthcare sector, has long been a stalwart in the pharmaceutical industry. Its robust market capitalization of $303.26 billion underscores its..

Exact Sciences Corporation (EXAS) Investor Outlook: Navigating Growth in the Diagnostics Sector

Exact Sciences Corporation (NASDAQ: EXAS), a leader in the healthcare sector, is making waves in the diagnostics and research industry with its innovative cancer screening and diagnostic test products. With..

Chemed Corp (CHE) Stock Analysis: Exploring a 17.39% Potential Upside with Strong Analyst Support

Chemed Corporation (NYSE: CHE) offers a unique proposition in the healthcare sector, presenting investors with a mix of steady revenue growth and robust operational efficiency. With a current market capitalization..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds